TyraTech, Inc.

("TyraTech" or the "Company")

Director's Dealings

TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified on 21 April 2015, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 555,780 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 5.14  pence per TyraTech share.

Mr & Mrs Reade then immediately repurchased 588,740 Common shares at 5.15 pence per TyraTech share; these shares being acquired equally into their respective ISA accounts.

Following these transactions, Alan Reade's beneficial interest in the Company has increased by 32,960 TyraTech shares to 12,733,616 TyraTech shares representing approximately 4.87% of the Company's issued share capital.

Enquiries: